Frontiers in Pharmacology (Nov 2019)

Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis

  • Shuang Dai,
  • Shuang Dai,
  • Shuang Dai,
  • Yuanliang Yan,
  • Yuanliang Yan,
  • Zhijie Xu,
  • Zhijie Xu,
  • Zhijie Xu,
  • Shuangshuang Zeng,
  • Shuangshuang Zeng,
  • Long Qian,
  • Long Qian,
  • Lei Huo,
  • Xuejun Li,
  • Lunquan Sun,
  • Zhicheng Gong,
  • Zhicheng Gong

DOI
https://doi.org/10.3389/fphar.2019.01358
Journal volume & issue
Vol. 10

Abstract

Read online

No abstracts available.

Keywords